|
Fine Organic Industries Limited (Fineorg.NS) Avaliação DCF
IN | Basic Materials | Chemicals - Specialty | NSE
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Fine Organic Industries Limited (FINEORG.NS) Bundle
Procurando avaliar o valor intrínseco da Fine Organic Industries Limited? Nossa calculadora DCF (fineorgns) integra dados do mundo real com extensos recursos de personalização, permitindo refinar suas previsões e aprimorar suas estratégias de investimento.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10,380.7 | 11,331.8 | 18,760.1 | 30,230.8 | 21,229.5 | 21,063.8 | 20,899.4 | 20,736.2 | 20,574.4 | 20,413.8 |
| Revenue Growth, % | 0 | 9.16 | 65.55 | 61.14 | -29.78 | -0.7806 | -0.7806 | -0.7806 | -0.7806 | -0.7806 |
| EBITDA | 2,606.6 | 2,163.5 | 3,975.7 | 8,952.4 | 6,054.7 | 5,204.0 | 5,163.3 | 5,123.0 | 5,083.0 | 5,043.4 |
| EBITDA, % | 25.11 | 19.09 | 21.19 | 29.61 | 28.52 | 24.71 | 24.71 | 24.71 | 24.71 | 24.71 |
| Depreciation | 346.6 | 467.7 | 399.0 | 478.9 | 562.8 | 582.5 | 578.0 | 573.5 | 569.0 | 564.6 |
| Depreciation, % | 3.34 | 4.13 | 2.13 | 1.58 | 2.65 | 2.77 | 2.77 | 2.77 | 2.77 | 2.77 |
| EBIT | 2,260.0 | 1,695.8 | 3,576.7 | 8,473.4 | 5,491.9 | 4,621.4 | 4,585.3 | 4,549.5 | 4,514.0 | 4,478.8 |
| EBIT, % | 21.77 | 14.97 | 19.07 | 28.03 | 25.87 | 21.94 | 21.94 | 21.94 | 21.94 | 21.94 |
| Total Cash | 2,104.2 | 2,637.4 | 2,325.6 | 5,257.5 | 10,485.1 | 5,170.0 | 5,129.6 | 5,089.6 | 5,049.8 | 5,010.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1,323.3 | 1,616.3 | 3,013.7 | 3,506.5 | 3,113.1 | 2,921.1 | 2,898.3 | 2,875.6 | 2,853.2 | 2,830.9 |
| Account Receivables, % | 12.75 | 14.26 | 16.06 | 11.6 | 14.66 | 13.87 | 13.87 | 13.87 | 13.87 | 13.87 |
| Inventories | 1,316.7 | 1,261.8 | 2,355.9 | 4,449.8 | 2,608.9 | 2,670.3 | 2,649.4 | 2,628.8 | 2,608.2 | 2,587.9 |
| Inventories, % | 12.68 | 11.13 | 12.56 | 14.72 | 12.29 | 12.68 | 12.68 | 12.68 | 12.68 | 12.68 |
| Accounts Payable | 857.5 | 977.8 | 1,535.5 | 1,758.3 | 1,354.1 | 1,570.1 | 1,557.8 | 1,545.7 | 1,533.6 | 1,521.6 |
| Accounts Payable, % | 8.26 | 8.63 | 8.19 | 5.82 | 6.38 | 7.45 | 7.45 | 7.45 | 7.45 | 7.45 |
| Capital Expenditure | -729.0 | -464.3 | -613.4 | -811.0 | -864.1 | -890.7 | -883.8 | -876.9 | -870.0 | -863.2 |
| Capital Expenditure, % | -7.02 | -4.1 | -3.27 | -2.68 | -4.07 | -4.23 | -4.23 | -4.23 | -4.23 | -4.23 |
| Tax Rate, % | 24.3 | 24.3 | 24.3 | 24.3 | 24.3 | 24.3 | 24.3 | 24.3 | 24.3 | 24.3 |
| EBITAT | 1,683.7 | 1,258.4 | 2,641.4 | 6,227.7 | 4,157.3 | 3,436.1 | 3,409.2 | 3,382.6 | 3,356.2 | 3,330.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -481.3 | 1,144.1 | 493.3 | 3,531.7 | 5,685.9 | 3,474.6 | 3,134.9 | 3,110.4 | 3,086.1 | 3,062.0 |
| WACC, % | 5.33 | 5.33 | 5.33 | 5.33 | 5.33 | 5.33 | 5.33 | 5.33 | 5.33 | 5.33 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 13,656.1 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 3,184 | |||||||||
| Terminal Value | 239,918 | |||||||||
| Present Terminal Value | 185,080 | |||||||||
| Enterprise Value | 198,736 | |||||||||
| Net Debt | -6,908 | |||||||||
| Equity Value | 205,644 | |||||||||
| Diluted Shares Outstanding, MM | 31 | |||||||||
| Equity Value Per Share | 6,707.25 |
What You Will Receive
- Authentic Fine Organic Data: Preloaded financials – covering everything from revenue to EBIT – based on actual and forecasted figures.
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates to fit your analysis.
- Instant Valuation Adjustments: Automatic recalculations to evaluate the impact of changes on the fair value of Fine Organic Industries Limited (FINEORGNS).
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and detailed projections.
- Efficient and Precise: Eliminate the need to build models from scratch while ensuring accuracy and adaptability.
Key Features
- Real-Life FINEORGNS Data: Pre-loaded with Fine Organic Industries Limited’s historical performance and future projections.
- Fully Customizable Inputs: Tailor revenue growth, profit margins, discount rates, tax rates, and capital expenditures to your preferences.
- Dynamic Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your entered data.
- Scenario Testing: Develop various forecasting scenarios to evaluate different valuation results.
- User-Friendly Design: Intuitive layout designed for both experienced professionals and newcomers.
How It Works
- Download the Template: Gain immediate access to the Excel-based FINEORGNS DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model will automatically compute Fine Organic Industries Limited's intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator for Fine Organic Industries Limited (FINEORGNS)?
- All-in-One Resource: Integrates DCF, WACC, and financial ratio analyses in a single platform.
- Flexible Inputs: Modify the yellow-highlighted cells to explore different scenarios.
- In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for Fine Organic Industries Limited.
- Preloaded Financial Data: Access to historical and projected data provides reliable starting points.
- Expert-Grade Tool: Perfect for financial analysts, investors, and business advisors.
Who Should Use This Product?
- Investors: Evaluate the intrinsic value of Fine Organic Industries Limited (FINEORGNS) before making investment choices.
- Financial Officers: Utilize a sophisticated DCF model for accurate financial reporting and analysis.
- Consultants: Easily customize the template for client valuation reports.
- Entrepreneurs: Discover financial modeling techniques employed by leading corporations.
- Educators: Implement it as a resource to teach valuation methods effectively.
Contents of the Template
- Preloaded FINEORGNS Data: Historical and forecasted financial information, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: High-quality spreadsheets designed for calculating intrinsic value and Weighted Average Cost of Capital.
- Customizable Inputs: Yellow-highlighted cells for modifying revenue growth, tax rates, and discount rates.
- Financial Statements: Detailed annual and quarterly financials for in-depth analysis.
- Key Ratios: Metrics for profitability, leverage, and efficiency to assess performance.
- Dashboard and Charts: Visual representations of valuation results and underlying assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.